¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Neonatal jaundice due to bleeding"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nonhemolytic jaundice
    ºñ¿ëÇ÷Ȳ´Þ
  • nuclear jaundice
    ÇÙȲ´Þ
  • obstructive jaundice
    Æó¼âȲ´Þ
  • regurgitation jaundice
    ¿ª·ùȲ´Þ
  • retention jaundice
    ü·ùȲ´Þ
  • urobilin jaundice
    ¿ì·Îºô¸°È²´Þ
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • neonatal
    ½Å»ý¾Æ-
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°, ½Å»ý¾Æ³ó·ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nonhemolytic jaundice
    ºñ¿ëÇ÷Ȳ´Þ
  • nuclear jaundice
    (¢¡kernicterus) ÇÙȲ´Þ
  • obstructive jaundice
    Æó¼âȲ´Þ
  • regurgitation jaundice
    ¿ª·ùȲ´Þ
  • retention jaundice
    ü·ùȲ´Þ
  • toxemic jaundice
    Áßµ¶È²´Þ
  • urobilin jaundice
    ¿ì·Îºô¸°È²´Þ
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á, ¿µ¾Æ»ç
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • renal dissociation jaundice
    ½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸).
  • renal dissociation jaundice
    ½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸)
  • abnormal uterine bleeding
    ÀÌ»óÀÚ±ÃÃâÇ÷(~í­Ïàõóúì).
  • acute gastrointestinal bleeding
    ±Þ¼º¼ÒÈ­°üÃâÇ÷, ±Þ¼ºÀ§Àå°üÃâÇ÷.
  • anovulatory bleeding
    ¹«¹è¶õ¼º ÃâÇ÷.
  • arterial bleeding
    µ¿¸ÆÃâÇ÷.
  • functional bleeding
    ±â´É¼º(ѦÒöàõ) ÃâÇ÷(õóúì).
  • functional bleeding
    ±â´ÉÀû ÃâÇ÷.
  • functional metrorrhagia =f. uterine bleeding
    ±â´É¼º ÀÚ±ÃÃâÇ÷.
  • gastric bleeding
    À§ÃâÇ÷.
  • gastrointestinal bleeding
    À§Àå°üÃâÇ÷.
  • gastrointestinal bleeding
    À§Àå°üÃâÇ÷
  • genital bleeding
    ¼º±âÃâÇ÷.
  • gingival bleeding
    Ä¡ÀºÃâÇ÷(öÍó»õóúì).
  • implantation bleeding
    Âø»óÃâÇ÷(ó·ßÉõóúì).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó(~ÙíѨøË).
  • neonatal blennorrh[o]ea
    ½Å»ý¾Æ ¾È³ó·ç
  • neonatal calf diarrhea coronavirus
    ½Å»ý¼Ò ¼³»ç Äڷγª¹ÙÀÌ·¯½º
  • neonatal cold injury
    ½Å»ý¾Æ ÇÑ·© ¼Õ»ó
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal death
    ½Å»ý¾Æ»ç¸Á(~ÞÝØÌ).
  • neonatal death
    ½Å»ý¾Æ»ç¸Á(~Ë×ËÎ).
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü(~ëÒ).
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü(~Ëô).
  • neonatal diarrhea ; diarrhea neonatorum
    ½Å»ý¾Æ¼³»ç.
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú(~ÊÖòð).
  • neonatal eruptive hemangiomatosis
    ¹ßÁø¼º ½Å»ý¾Æ Ç÷°üÁ¾Áõ
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ðÁõ(~÷­Ù¾ñø).
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ðÁõ
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°(~ÊÜæú).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • petechial bleeding
    Á¡»óÃâÇ÷
  • postpartum bleeding
    ºÐ¸¸ÈÄÃâÇ÷
  • retinal bleeding
    ¸Á¸·ÃâÇ÷
  • spontaneous bleeding
    ÀÚ¿¬ÃâÇ÷
  • upper gastrointestinal bleeding
    »óºÎÀ§Àå°üÃâÇ÷
  • uterine bleeding
    ÀÚ±ÃÃâÇ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
dt due to; dystonic
DUE drug use evaluation
EDD effective drug duration; electron dense deposit; end-diastolic dimension; esophageal detection devic...
HSAS hydrocephalus due to stenosis of aqueduct of Sylvius; hypertrophic subaortic stenosis
BT   1) Bleeding Time
  2) Body Temperature
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BT Bleeding Time
BOP Bleeding on Probing
BTB Breakthrough bleeding
DUB Dysfunctional uterine bleeding
GIB Gastrointestinal Bleeding
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal blennorrhea
    ½Å»ý¾Æ ¾È ³ó·ç
  • neonatal calf diarrhea corona virus
    ½Å»ý¾Æ ¼³»ç Äڷγª ¹ÙÀÌ·¯½º
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • neonatal diarrhea
    ½Å»ý¾Æ ¼³»ç
  • neonatal eruptive hemangiomatosis
    ¹ßÁø¼º ½Å»ý¾Æ Ç÷°üÁ¾Áõ
  • neonatal hepatitis
    ½Å»ý¾Æ °£¿°
  • neonatal infection
    ½Å»ý¾Æ °¨¿°
  • neonatal line
    ù ¼ºÀå¼±
  • neonatal maxillitis
    ½Å»ý¾Æ »ó¾Ç°ñ
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • neonatal tetany
    ½Å»ý¾Æ Åן´Ï
  • neonatal thyrombocytopenia
    ½Å»ý¾Æ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • abnormal uterine bleeding
    ÀÌ»ó Àڱà ÃâÇ÷
    ÀÚ±ÃÀ¸·ÎºÎÅÍ Çǰ¡ ºñÁ¤»óÀûÀ¸·Î ³ª¿À´Â °Í. ¿ù°æÀÇ °æ¿ì¸¦ Á¦¿ÜÇϰí´Â ºñÁ¤»ó ÃâÇ÷·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
anaemia, neonatal The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation.
(12 Dec 1998)
benign neonatal convulsions A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance.
(05 Mar 2000)
Brazelton's Neonatal Behavioural Assessment Scale A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
neonatal diagnosis Systematic evaluation of the newborn for evidence of disease or malformations, and the conclusion reached.
(05 Mar 2000)
neonatal diseases and abnormalities Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á